Marcus‐Alexander Wörns

2.3k total citations
74 papers, 1.3k citations indexed

About

Marcus‐Alexander Wörns is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Marcus‐Alexander Wörns has authored 74 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Hepatology, 45 papers in Epidemiology and 20 papers in Surgery. Recurrent topics in Marcus‐Alexander Wörns's work include Liver Disease Diagnosis and Treatment (39 papers), Liver Disease and Transplantation (36 papers) and Hepatocellular Carcinoma Treatment and Prognosis (23 papers). Marcus‐Alexander Wörns is often cited by papers focused on Liver Disease Diagnosis and Treatment (39 papers), Liver Disease and Transplantation (36 papers) and Hepatocellular Carcinoma Treatment and Prognosis (23 papers). Marcus‐Alexander Wörns collaborates with scholars based in Germany, United States and Italy. Marcus‐Alexander Wörns's co-authors include Peter R. Galle, Christian Labenz, Jörn M. Schattenberg, Jens U. Marquardt, Yvonne Huber, Gerrit Toenges, Michael Nagel, Arndt Weinmann, Martin F. Sprinzl and Michael Nagel and has published in prestigious journals such as The Lancet, Gastroenterology and PLoS ONE.

In The Last Decade

Marcus‐Alexander Wörns

74 papers receiving 1.2k citations

Peers

Marcus‐Alexander Wörns
Eileen L. Yoon South Korea
Ewa Wunsch Poland
Peter Konyn United States
Howard Hampel United States
Brian Davis United States
Munkhzul Otgonsuren United States
Hong‐Zen Yeh Taiwan
Tatsuya Minami Japan
Chia‐Chang Hsu Taiwan
Christoph Jüngst Germany
Eileen L. Yoon South Korea
Marcus‐Alexander Wörns
Citations per year, relative to Marcus‐Alexander Wörns Marcus‐Alexander Wörns (= 1×) peers Eileen L. Yoon

Countries citing papers authored by Marcus‐Alexander Wörns

Since Specialization
Citations

This map shows the geographic impact of Marcus‐Alexander Wörns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus‐Alexander Wörns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus‐Alexander Wörns more than expected).

Fields of papers citing papers by Marcus‐Alexander Wörns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus‐Alexander Wörns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus‐Alexander Wörns. The network helps show where Marcus‐Alexander Wörns may publish in the future.

Co-authorship network of co-authors of Marcus‐Alexander Wörns

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus‐Alexander Wörns. A scholar is included among the top collaborators of Marcus‐Alexander Wörns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus‐Alexander Wörns. Marcus‐Alexander Wörns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Labenz, Christian, Anita Arslanow, M Nguyen-Tat, et al.. (2022). Structured Early detection of Asymptomatic Liver Cirrhosis: Results of the population-based liver screening program SEAL. Journal of Hepatology. 77(3). 695–701. 29 indexed citations
2.
Kaps, Leonard, Michael Nagel, Maurice Stephan Michel, et al.. (2022). Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis. Clinics and Research in Hepatology and Gastroenterology. 46(4). 101873–101873. 5 indexed citations
3.
Kaps, Leonard, Michael Nagel, Maurice Stephan Michel, et al.. (2021). Risk factors for poorer health literacy in patients with liver cirrhosis. PLoS ONE. 16(7). e0255349–e0255349. 21 indexed citations
4.
Gairing, Simon Johannes, Carolin Czauderna, Thomas Thomaidis, et al.. (2021). Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancer. JHEP Reports. 4(3). 100417–100417. 10 indexed citations
5.
Michel, Maurice Stephan, Francesca Romana Spinelli, Annette Grambihler, et al.. (2021). Health-related quality of life in patients with autoimmune hepatitis. Quality of Life Research. 30(10). 2853–2861. 5 indexed citations
6.
Labenz, Christian, Michael Nagel, Gerrit Toenges, et al.. (2020). Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosis. European Journal of Internal Medicine. 82. 83–89. 3 indexed citations
7.
Labenz, Christian, Gerrit Toenges, Jörn M. Schattenberg, et al.. (2019). Health-related quality of life in patients with compensated and decompensated liver cirrhosis. European Journal of Internal Medicine. 70. 54–59. 41 indexed citations
8.
Kaps, Leonard, Annette Grambihler, Michael Nagel, et al.. (2019). Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC). Digestive Diseases and Sciences. 65(10). 3006–3013. 15 indexed citations
9.
Foerster, Friedrich, Maria Hoppe‐Lotichius, Jens U. Marquardt, et al.. (2019). Long‐term observation of hepatocellular carcinoma recurrence after liver transplantation at a European transplantation centre. United European Gastroenterology Journal. 7(6). 838–849. 26 indexed citations
10.
Sprinzl, Martin F., Martha M. Kirstein, Sandra Koch, et al.. (2018). Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular Carcinoma. Liver Cancer. 8(5). 387–402. 19 indexed citations
11.
Wörns, Marcus‐Alexander & Peter R. Galle. (2018). Two large steps forward, one small step back. Nature Reviews Gastroenterology & Hepatology. 15(2). 74–76. 14 indexed citations
12.
Wörns, Marcus‐Alexander & Peter R. Galle. (2018). Patient prioritisation in HCC treatment: All (good) things come in threes. Journal of Hepatology. 68(6). 1311–1312. 1 indexed citations
13.
Foerster, Friedrich, Jens Mittler, Michael Heise, et al.. (2018). Recipient liver function before liver transplantation influences post-transplantation survival in patients with HCC. European Journal of Internal Medicine. 55. 57–65. 6 indexed citations
14.
Labenz, Christian, Sandra Koch, Yvonne Huber, et al.. (2017). Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib. Digestive Diseases. 36(1). 78–88. 7 indexed citations
15.
Kirstein, Martha M., Torsten Voigtländer, Nóra Schweitzer, et al.. (2017). Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic disease. United European Gastroenterology Journal. 6(2). 238–246. 16 indexed citations
16.
Czauderna, Carolin, Jens U. Marquardt, Peter R. Galle, & Marcus‐Alexander Wörns. (2017). Das hepatozelluläre Karzinom. Der Internist. 58(5). 469–479. 1 indexed citations
17.
Wörns, Marcus‐Alexander & Peter R. Galle. (2014). HCC therapies—lessons learned. Nature Reviews Gastroenterology & Hepatology. 11(7). 447–452. 115 indexed citations
18.
Wörns, Marcus‐Alexander, Sandra Koch, M Nguyen-Tat, et al.. (2012). Clinicopathologic Features and Prognosis of Young Patients With Hepatocellular Carcinoma in a Large German Cohort. Journal of Clinical Gastroenterology. 46(9). 775–778. 13 indexed citations
19.
20.
Schuchmann, Marcus, Henning Schulze‐Bergkamen, Jörn M. Schattenberg, et al.. (2006). Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy. Oncology Reports. 15(1). 227–30. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eileen L. Yoon Breakdown of academic impact, for papers by Ewa Wunsch Breakdown of academic impact, for papers by Peter Konyn Breakdown of academic impact, for papers by Howard Hampel Breakdown of academic impact, for papers by Brian Davis Breakdown of academic impact, for papers by Munkhzul Otgonsuren Breakdown of academic impact, for papers by Hong‐Zen Yeh Breakdown of academic impact, for papers by Tatsuya Minami Breakdown of academic impact, for papers by Chia‐Chang Hsu Breakdown of academic impact, for papers by Christoph Jüngst
Rankless by CCL
2026